Neuralstem Reports Year End 2018 Fiscal Results Nasdaq
GERMANTOWN, Md., March 22, 2019– Neuralstem, Inc., a biopharmaceutical company focused on the development of nervous system therapies based on its.
Neuralstem Reports Year End 2018 Fiscal Results Nasdaq
GERMANTOWN, Md., March 22, 2019– Neuralstem, Inc., a biopharmaceutical company focused on the development of nervous system therapies based on its.